Vanta Bioscience Ltd - 540729 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 4th AGM held on 30.09.202001-10-2020
Vanta Bioscience Ltd - 540729 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 4th AGM held on 30.09.2020Vanta Bioscience Ltd - 540729 - Reg. 34 (1) Annual Report
We enclose herewith the annual report of the Company for financial year 2019-20 including the Notice of the 4th AGMVanta Bioscience Ltd - 540729 - Annual General Meeting On September 30, 2020
The 4th annual general meeting of the Company will be held on September 30, 2020 through Video Conferencing/other Audio Visual MeansVanta Bioscience Ltd - 540729 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation regarding downgrade in credit rating by India Rating and ResearchVanta Bioscience Ltd - 540729 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Zoheb SayaniDesignation :- Company Secretary and Compliance OfficerVanta Bioscience Ltd - 540729 - Outcome Of Board Meeting Held On 30.06.2020
Outcome of Board Meeting held on 30.06.2020Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Approval Of Audited Financial Statements For The Half Year And Year Ended March 31, 2020
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve the standalone and consolidated audited financial statements of the Company for the half year and year ended March 31, 2020 and other matters.Vanta Bioscience Ltd - 540729 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We wish to inform you that a zoom webinar is being organized by Corporate Capital Ventures on the topic 'SUSTAIN & EMERGE POST COVID - 19' which shall have an interaction with Mr. Dopesh Raja Mulakala, Managing Director of the Company The said webinar is being organized for the benefit of investors and is open for all registered delegates. The following is the link to attend/register for the same: https://us02web.zoom.us/webinar/register/WN_CvV_uaavToiEqV7W_KDXBA Schedule - Friday, June 19, 2020 05:00 PMVanta Bioscience Ltd - 540729 - Compliance Certificate Under Reg 7(3) For The Half Year Ended 31.03.2020
Compliance Certificate under Reg 7(3) for the half year ended 31.03.2020